用户中心
用户中心
排名不分先后次序
|
姓名 |
单位 |
报告题目 |
|
Dubreuil Luc |
University of Lille II, France |
Facing the antibiotic resistance drug bugshistory and future |
|
Philippe Chavatte |
Judicial Expert at the Court of Appeal of Douai (Drug Sciences) Expert at the General Direction of Research and Innovation |
PPAR gamma: new target for old diseases |
|
John A. Katzenellenbogen |
Department of Chemistry, University of Illinois at Urbana-Champaign |
Estrogens and Estrogen Receptors: Structure, Function, and In Vivo Imaging |
|
Benita S.
Katzenellenbogen |
Departments of Molecular and Integrative Physiology, and Cell and Developmental Biology, University of Illinois at Urbana-Champaign |
PATHWAYS AND PHARMACOLOGY OF Estrogens and Estrogen Receptor ACTIONs |
|
张礼和 |
北京大学药学院 |
待定 |
|
陈凯先 |
上海药物所 |
待定 |
|
Richard D. Cramer |
Senior Vice President, Chief Scientific Officer, Tripos |
Benefits of topomers in drug discovery: an overview |
|
Albert S. C. Chan
陈新滋
|
The Hong Kong Polytechnic University |
待定 |
|
Richard M. Kellogg |
Groningen University, Netherlands |
A New Route to Enantiomerically Pure Compounds Including Drugs and Drug Intermediates Using Attrition-Induced Grinding of Conglomerate Crystals |
|
林国强 |
上海有机所 |
待定 |
|
赵玉芬 |
厦门大学 |
待定 |
| Emmanuel Bertounesque | CNRS UMR 176-Institut Curie, Centre de Recherche | Searching for non-peptidic inhibitors of Grb2-SH2 domain |
|
蒋华良 |
上海药物所 |
待定 |
|
程卯生 |
沈阳药科大学 |
Studies on PAKs signal pathways for new anticancer drugs discovery |
|
马大为 |
上海有机所 |
Amino acid promoted Ullmann-type coupling reactions and their applications in the assembly of pharmaceutically important heterocycles |
|
郭涛 |
药明康德, CGP-Doering Foundation基金会总裁兼首席执行官 |
Structure-based design and synthesis of novel BACE-1 inhibitors for Alzheimer’s Disease |
|
Hans-Josef Altenbach |
德国WUPPERTAL University |
Sugar Analogues as Enzyme Inhibitors, Signalling Molecules and Potential Drugs |
|
向家宁 |
葛兰素-史克上海研发中心化学部负责人 |
Design Optimization for Prodrugs |
| 田振平 | Hutchison MediPharma | Process Development of Fiduxosin Hydrochloride-A Drug Failed in the Last Minute |
| 陈芬儿 | 复旦大学化学系 | (+)-喜树碱类抗肿瘤药物的的不对称全合成 |
| 段践辛 | Schrodinger Inc |
ENERGY-BASED PHARMACOPHORE HYPOTHESES DERIVED FROM FRAGMENT DOCKING |
|
沈竞康 |
中国科学院上海药物研究所 |
新药研究的十字路口(综述及展望） |
|
尤启冬 |
中国药科大学药学院 |
Novel N-Hydroxyb enzamides base d HDAC Inhibitors with Remarkable Subtype Selec'tivity |
|
陈基旺 |
国立台湾大学药学系 |
Synthesis and Development of Multi-kinase Inhibitors as Potential Anticancer Agents |
|
CHUNG-MING SUN (孫仲銘) |
Department of Applied Chemistry, National Chiao-Tung University, Hsinchu, Taiwan | Traceless Synthesis of tetrahydro-β-Carboline Fused Oxo and Thio Hydantoins on Ionic Liquid Support in Green Solvents |
|
吴建国 |
病毒学国家重点实验室 |
待定 |
|
Wei-Min Dai |
Department of Chemistry, The Hong Kong University of Science and Technology |
Ring-closing metathesis of the grafted substrates developed for total synthesis of 24-demethylbafilomycin C1 |
|
Chenglong Li |
The Ohio State University |
A novel mutiple ligand simultaneous docking (MLSD) method for fragment-based drug design (FBDD) |
| Xiandan Lu | Biogen Idec | Today’s Small Molecule Drug Discovery: Issues, Tactics, and Platforms |
| Joe Shih | Eli Lilly | The Discovery and Development of ALIMTA? an Exciting Antifolate Anticancer Agent for Malignant Pleural Mesothelioma and Non-Small Cell Lung Cancer |
|
娄红祥 |
Department of natural products chemistry School of Pharmaceutical Sciences Shandong University |
Macrocyclic bisbibenzyl derivatives and their biological significances |
|
张亮仁 |
北京大学药学院 |
以Vif为靶点的抗HIV-1药物先导结构的发现 |
|
柏旭 |
吉林大学 |
探索药物发明的新策略与新型p38a抑制剂的发现 |
|
胡永洲 |
浙江大学创新药物研究中心 |
咔啉类衍生物的设计, 合成与抗肿瘤活性研究 |
|
徐文方 |
山东大学药学院 |
The discovery of anticancer agents based on APN/CD13 as target |
|
王任小 |
上海有机所 |
待定 |
|
姜凤超 |
华中科技大学同济医学院 |
疾病的病因网络与药物设计 |
|
刘宏民 |
郑州大学药学院 |
新型高碳糖的合成方法学研究 |
|
吴勇 |
四川大学华西药学院 |
脑靶向药物研究 |
|
谢兰 |
Beijing Institute of Pharmacology & Toxicology |
作用于HIV-1 gp41的非肽类小分子融合抑制剂先导物的发现和优化 |
|
张三奇 |
西安交通大学医学院药物研究所 |
2-取代-3, 4-二氢-1-异喹啉酮的合成和舒张血管活性 |
|
张奕华 |
中国药科大学 |
一氧化氮供体型抗肿瘤药物研究 |
|
郑江 |
Department of Pediatrics, School of Medicine, University of Washington |
Targeting Glutathione S-Transferase: A Strategy to Combat Chemotherapy Resistance |
|
周 翔 |
武汉大学化学与分子科学学院 |
待定 |
| 陈建国 | 华中科技大学 | 待定 |
|
杨光富 |
华中师范大学化学系 |
计算突变扫描:一种药物抗性预测新方法 |
|
胡有洪 |
Shanghai Institute of Materia Medica,
Chinese Academy of Science |
多样性小分子库的合成及活性先导化合物的发现 |
|
方唯硕 |
中国医学科学院药物研究所研究员 |
D-seco紫杉烷的合成及其与微管的相互作用: 从抗肿瘤到治疗阿尔茨海默氏症? |
|
周成合 |
西南大学化学化工学院化学系 |
超分子药物-概念与前景(Supramolecular Drugs-Concepts and Perspectives) |
|
朱耀球 |
MetabQuest Research and Consulting (Beijing/Chicago) |
New Drug Design and Optimization Based on Early ADME-tox Studies |
|
Zhaokui Wan |
Wyeth Research, US |
待定 |
|
Junjun Wu |
Wyeth Research, US |
Discovery of Novel and Potent p38 Kinase Inhibitors |
| 何祥久 | 武汉大学药学院 | 天然活性化合物生物转化研究 |
| 周海兵 | 武汉大学药学院 |
新型选择性雌激素受体调节剂(SERMs) 的设计, 合成及生物活性研究 |
| 肖玉玲 | 武汉大学药学院 |
待定 |
Copyright(C) 2009年全国药物化学学术会议